1-methyl-3-isobutylxanthine has been researched along with Eye Cancer, Retinoblastoma in 2 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Remessy, AE | 1 |
Rabie, AM | 1 |
El-Shishtawy, MM | 1 |
Eissa, LA | 1 |
Liou, GI | 1 |
Pierce, ME | 1 |
Barker, D | 1 |
Harrington, J | 1 |
Takahashi, JS | 1 |
2 other studies available for 1-methyl-3-isobutylxanthine and Eye Cancer, Retinoblastoma
Article | Year |
---|---|
Regulation of interphotoreceptor retinoid-binding protein (IRBP) gene expression by cAMP in differentiated retinoblastoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Actins; Blotting, Northern; Cell Differentiation; Colforsin; Cyclic AMP | 2000 |
Cyclic AMP-dependent melatonin production in Y79 human retinoblastoma cells.
Topics: 1-Methyl-3-isobutylxanthine; 5-Hydroxytryptophan; 8-Bromo Cyclic Adenosine Monophosphate; Colforsin; | 1989 |